Search for Clinical Trial Results

Sponsored By

Neuroectodermal Tumors, Primitive, Peripheral - 25 Studies Found

Status Study
Completed Study Name: BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy.
Condition: Pancreatic Neuroendocrine Tumors (pNET)
Date: 2012-07-06
Interventions: Drug: BEZ235 (Stage 1) The investigational study drug used in this trial was BEZ235, which was supplied
Active, not recruiting Study Name: Concurrent Carboplatin and Reduced Dose Craniospinal Radiation for Medulloblastoma and Primitive Neuroectodermal Tumor (PNET)
Condition:
  • Metastatic Medulloblastoma
  • High Risk Supratentorial PNET
    • <
    Date: 2012-02-27
    Interventions:
    • Drug: Carboplatin Administered
Completed Study Name: IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid Tumor
Condition:
  • Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
  • Biological: cixutumumab Given

Completed Study Name: High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood
Condition:
  • Medulloblastoma
  • Brain Tumors
  • Neuroectodermal Tumors, Primi
    Date: 2005-09-09
    Interventions: Drug: Etoposide, carboplatin, melphalan, cisplatin, thiotepa
Completed Study Name: Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma
Condition: Sarcoma
Date: 1999-11-01
Interventions:
  • Biological: filgrastim
  • Drug: busulfan
Completed Study Name: Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer
Condition:
  • Kidney Cancer
  • Sarcoma

Date: 1999-11-01
Interventions:
  • Drug: cyclophosphamide
  • Drug: doxorubicin h
Completed Study Name: Study of Tumor Samples From Patients With Ewing Sarcoma
Condition: Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
Date: 2009-05-09
Interventions: Other: laboratory biomarker analysis Correlative studies
Completed Study Name: Genetic Biomarkers in Saliva Samples From Patients With Ewing Sarcoma
Condition: Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET)
Date: 2013-06-10
Interventions:
  • Other: laboratory biomarker analysis

Recruiting Study Name: Efficacy and Safety of Everolimus and (STZ-5FU) Given One Upfront the Other Upon Progression in Advanced pNET
Condition: Pancreatic Neuroendocrine Tumours.
Date: 2014-08-20
Interventions:
  • Drug: Drug: Everolimus 10mg/da
Terminated Study Name: Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET
Condition: Islet Cell Tumor
Date: 2011-06-14
Interventions:
  • Drug: Everolimus Everolimus wa
Next >>>